Literature DB >> 15625284

Circulating insulin-like growth factor-1 and insulin-like growth factor binding protein-3 are associated with early carotid atherosclerosis.

Shin-ichi Kawachi1, Noriyuki Takeda, Akihiko Sasaki, Yoshiaki Kokubo, Kazuhisa Takami, Hiroshi Sarui, Makoto Hayashi, Noriyoshi Yamakita, Keigo Yasuda.   

Abstract

OBJECTIVE: Growth hormone (GH)-insulin-like growth factor (IGF)-1 axis regulates growth and survival of vascular cells and cardiomyocytes. The role of GH-IGF-1 axis in cardiovascular disease is controversial. METHODS AND
RESULTS: We assessed the association of circulating levels of IGF-1 and IGF binding protein-3 (IGFBP-3) with early carotid atherosclerosis and atherosclerotic risk factors in 330 Japanese men (age 51.6+/-8.6 years, range 29 to 77, body mass index [BMI] 23.6+/-2.9 kg/m2). Intima-media thickness (IMT) of the common carotid artery was measured by ultrasound. Abdominal visceral adipose and subcutaneous adipose tissue area by computer-assisted tomographic scan were determined. Correlation coefficients were calculated by partial correlation analysis. BMI and plasma insulin showed positive associations with circulating IGF-1 and IGFBP-3. Subcutaneous adipose tissue was correlated with IGF-1. High-density lipoprotein cholesterol was inversely associated with IGF-1. Blood pressure, total cholesterol, triglyceride, and visceral adipose tissue were positively associated with IGFBP-3. IGF-1 and IGFBP-3 were associated with carotid IMT independent of age, BMI, blood pressure, and insulin. Insulin was associated with carotid IMT in univariate analysis. However, it was not correlated with carotid IMT in the multivariate analyses which included IGF-1 or IGFBP-3 as a covariate.
CONCLUSIONS: Increased circulating IGF-1 and IGFBP-3 may be stimulators of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15625284     DOI: 10.1161/01.ATV.0000154486.03017.35

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  34 in total

Review 1.  Hormone replacement therapy and physical function in healthy older men. Time to talk hormones?

Authors:  Manthos G Giannoulis; Finbarr C Martin; K Sreekumaran Nair; A Margot Umpleby; Peter Sonksen
Journal:  Endocr Rev       Date:  2012-03-20       Impact factor: 19.871

2.  Vitamin D modulates the association of circulating insulin-like growth factor-1 with carotid artery intima-media thickness.

Authors:  Pietro Ameri; Marco Canepa; Patrizia Fabbi; Giovanna Leoncini; Yuri Milaneschi; Michele Mussap; Majd AlGhatrif; Manrico Balbi; Francesca Viazzi; Giovanni Murialdo; Roberto Pontremoli; Claudio Brunelli; Luigi Ferrucci
Journal:  Atherosclerosis       Date:  2014-08-12       Impact factor: 5.162

3.  IGF-1 has plaque-stabilizing effects in atherosclerosis by altering vascular smooth muscle cell phenotype.

Authors:  Jan H von der Thüsen; Keren S Borensztajn; Silvia Moimas; Sandra van Heiningen; Peter Teeling; Theo J C van Berkel; Erik A L Biessen
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

4.  Use of ACE inhibitors is associated with elevated levels of IGFBP-3 among hypertensive older adults: results from the IlSIRENTE study.

Authors:  Graziano Onder; Rosa Liperoti; Andrea Russo; Ettore Capoluongo; Angelo Minucci; Paola Lulli; Matteo Cesari; Marcello Maggio; Roberto Bernabei; Francesco Landi
Journal:  Eur J Clin Pharmacol       Date:  2007-02-02       Impact factor: 2.953

5.  Anti-atherosclerotic actions of azelaic acid, an end product of linoleic acid peroxidation, in mice.

Authors:  Dmitry Litvinov; Krithika Selvarajan; Mahdi Garelnabi; Larissa Brophy; Sampath Parthasarathy
Journal:  Atherosclerosis       Date:  2009-10-12       Impact factor: 5.162

Review 6.  IGF-1 and cardiovascular disease.

Authors:  Yusuke Higashi; Sandeep Gautam; Patrick Delafontaine; Sergiy Sukhanov
Journal:  Growth Horm IGF Res       Date:  2019-01-31       Impact factor: 2.372

7.  Hepatic JAK2 protects against atherosclerosis through circulating IGF-1.

Authors:  Tharini Sivasubramaniyam; Stephanie A Schroer; Angela Li; Cynthia T Luk; Sally Yu Shi; Rickvinder Besla; David W Dodington; Adam H Metherel; Alex P Kitson; Jara J Brunt; Joshua Lopes; Kay-Uwe Wagner; Richard P Bazinet; Michelle P Bendeck; Clinton S Robbins; Minna Woo
Journal:  JCI Insight       Date:  2017-07-20

8.  SM22α (Smooth Muscle Protein 22-α) Promoter-Driven IGF1R (Insulin-Like Growth Factor 1 Receptor) Deficiency Promotes Atherosclerosis.

Authors:  Sergiy Sukhanov; Yusuke Higashi; Shaw-Yung Shai; Patricia Snarski; Svitlana Danchuk; Veronica D'Ambra; Michael Tabony; T Cooper Woods; Xuwei Hou; Zhaohui Li; Atsufumi Ozoe; Bysani Chandrasekar; Shin-Ichiro Takahashi; Patrice Delafontaine
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-10       Impact factor: 8.311

Review 9.  IGF-1, oxidative stress and atheroprotection.

Authors:  Yusuke Higashi; Sergiy Sukhanov; Asif Anwar; Shaw-Yung Shai; Patrice Delafontaine
Journal:  Trends Endocrinol Metab       Date:  2010-01-12       Impact factor: 12.015

10.  Water-Soluble Components of Sesame Oil Reduce Inflammation and Atherosclerosis.

Authors:  Chandrakala Aluganti Narasimhulu; Krithika Selvarajan; Kathryn Young Burge; Dmitry Litvinov; Bhaswati Sengupta; Sampath Parthasarathy
Journal:  J Med Food       Date:  2016-06-27       Impact factor: 2.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.